Question: is kalydeco a cure for cf?
Answer: No one discontinued treatment because of safety concerns. The most common side effects included coughing, fever, increased liver enzyme levels, and a runny nose. Based on these results, the FDA approved Kalydeco in August 2018 to treat cystic fibrosis patients ages 12-24 months with any of these 10 mutations.